{"created":"2014-10-08T15:57:20+00:00","modified":"2014-10-31T02:00:25+00:00","valid":{"from":"2014-10-31T02:00:25+00:00","to":"3014-10-31T02:00:25+00:00"},"hreflang":"en","title":"To Pay For Hepatitis C Drugs, Medicare Might Face A Steep Bill","published":"2014-05-17T00:00:00+00:00","teaser":"The federal Medicare program for the elderly and disabled will cover two new drugs that can cure hepatitis C, a liver disease that can cause cancer and lead to death. The drugs are very expensive, but they cure hepatitis C in most cases. The government and insurers are concerned about these costs; three million Americans have hepatitis C, most of whom don't know they have it.","itags":["npr_api","313154941"],"guid":"5456495f-e85f-4b00-8539-3c640c3c73a9","contentencoded":"<p><div class=\"fullattribution\">Copyright 2014 NPR. To see more, visit <a href=\"http://www.npr.org/\">http://www.npr.org/</a>.<img src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=To+Pay+For+Hepatitis+C+Drugs%2C+Medicare+Might+Face+A+Steep+Bill&utme=8(APIKey)9(MDAyOTcwNDAwMDEyODgyMDkwMTgwNzY3YQ001)\"/></div></p>","byline":"Melissa Block","audio":[{"meta":{"duration":"242"},"type":"audio/m3u","href":"http://api.npr.org/m3u/1313154942-3bbd46.m3u?orgId=1&topicId=1027&ft=3&f=313154941"}]}